1320_PR: Subgroup analyses of patients with epidermal growth factor receptor (EGFR)-expressing tumors in SQUIRE: A randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin (GC) plus necitumumab (N) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC)
- Paz-Ares, L.
- Socinski, M.A.
- Shahidi, J.
- Hozak, R.R.
- Soldatenkova, V.
- Thatcher, N.
- Hirsch, F.
ISSN: 1556-1380, 1556-0864
Año de publicación: 2016
Volumen: 11
Número: 4
Páginas: S153
Tipo: Artículo